SCHEMBL6995067

SCHEMBL6995067

O=C1c2ccccc2-c2[nH]nc(-c3cccs3)c21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 10/20 0.57
CCND1 P24385 10/20 0.57
CCNE2 O96020 10/20 0.57
CCNE1 P24864 10/20 0.57
CDK2 P24941 10/20 0.57
ADORA2A P29274 2/20 0.55
ADORA1 P30542 1/20 0.55
KDR P35968 1/20 0.50
HSD17B10 Q99714 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ALPL P05186 1/20 0.47
HPGD P15428 1/20 0.47
POLB P06746 2/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024007 0.79 CCNE2 (0.86) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL4025768 0.77 CCNE2 (0.86) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7090159 0.76 CDK4 (0.71) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7148608 0.76 CDK4 (0.66) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL4024001 0.73 CCNE2 (1.00) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL4026800 0.73 CDK4 (0.87) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7145484 0.72 CDK4 (0.68) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7146443 0.72 CDK4 (0.68) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL4816704 0.72 CDK4 (0.68) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL4025763 0.71 CCNE2 (1.00) CDK4CCND1CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed